leisure time -WSS

leisure time

author：explore 2025-09-30 18:54:54 - browse：171

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： 10 reasons why health care startups fail

Wikipedia

WSS

NYU Langone launches private ChatGPT for its health care data

Appeals court upholds limits to abortion pill

New clues to why women have higher risk of autoimmune disorders

CDC advisory panel says seniors 'may' get RSV vaccine

Why more medical students aren't specializing in primary care

Humana’s losses in Medicare Advantage tank its stock

entertainment

leisure time

hotspot

In age of alternative facts, a scholarly course on calling out crap

Venture capital firm's plans to take over Akron hospital face hurdles

Bright Health sells Medicare Advantage business to Molina

How a symptom of dementia informs our understanding of creativity

Novavax promises a turnaround & Lilly roils the obesity market

Wegovy leads to weight loss. Can it treat depression, too?

Peter Hotez and the public health issue of online harassment

Reconstructing family trees of blood cells may help predict disease

Malaria cases in Florida and Texas: Here’s what you need to know

CDC advisory panel says seniors 'may' get RSV vaccine

focus

FDA panel gives mixed vote on blood pressure devices

AstraZeneca bets AAV gene therapy will still deliver the goods

Syphilis numbers in the United States reach record heights

How generative AI ratchets up security threats for health systems

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Complete sequence of Y chromosome published for first time

entertainment

Wikipedia

explore

hotspot